Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzheimer’s

Showing 15 posts of 151 posts found.

psm_v46_d168_mesial_view_of_the_human_brain

Novartis and Amgen halt trials into Alzheimer’s drug after patients get worse

July 12, 2019
Medical Communications Alzheimer's, Amgen, Banner Alzheimer's Institute, Novartis, dementia, pharma, research

Novartis, Amgen and Banner Alzheimer’s Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient’s conditions …

News

Pfizer supressed research suggesting arthritis drug Enbrel reduced risk of Alzheimer’s by 64%

June 6, 2019
Research and Development Alzheimer's, Drug therapy, Pfizer, dementia, pharma

Pfizer supressed data suggesting that their drug Enbrel reduced the risk of patients developing Alzheimer’s disease by 64%. In 2015, …

News
astrocyte5

Scientists identify new form of dementia

May 1, 2019
Research and Development AD, Alzheimer's, dementia, late, neuroscience

A team of scientists from Britain and the United States have described a new form of dementia, according to a …

News

Google accused of profiting from misleading dementia supplement ads

March 26, 2019
Manufacturing and Production Alzheimer's, dementia, google, pseudomedicine, search engines, tech

Google has been accused of profiting from false hope after running adverts for unproven dementia treatments which can cost as …

News
eisa0008_web

Biogen and Eisai discontinue Phase 3 Alzheimer’s trial

March 21, 2019
Research and Development Alzheimer's, Biogen, CNS, Eisai, mental health

Biogen and Eisai have announced their decision to discontinue a Phase 3 trial looking into the efficacy and safety of …

News
astrocyte5

Antiepileptics increase the risk of pneumonia in people with Alzheimer’s disease

March 21, 2019
Research and Development Alzheimer's, R&D, adverse events, antiepileptic drugs, epilepsy, pneumonia

Antiepileptic drugs increase the risk of pneumonia in people living with Alzheimer’s disease, according to research from the University of …

News
5204602349_c87b204860_z

FDA to crack down on dietary supplements

February 12, 2019
Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes

The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …

News
shutterstock_38078521

Roche pulls plug on Alzheimer’s drug after Phase 3 failure

January 30, 2019
Research and Development AC Immune, Alzheimer's, Roche, crenezumab, pharma

Roche has announced that it is to terminate two Phase 3 studies investigating the efficacy of its anti-beta-amyloid molecule crenezumab …

News

People in England will be able to pay the NHS to sequence their genetic data, if they share it with scientists

January 28, 2019
Sales and Marketing Alzheimer's, Cancer, England, NHS, genetic data, genomes, health

The NHS will provide paid-for health reports, informing patients as to the likelihood that they will develop diseases such as …

News
394px-ad_versus_co

UK Dementia partnership offering £100,000-200,000 awards for dementia research projects

October 23, 2018
Manufacturing and Production Alzheimer's, dementia, development, research

The Dementia Discovery Fund (DDF) in partnership with the UK Dementia Research Institute (UK DRI) has announced that it will …

News
alzheimers_sq

Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership

October 8, 2018
Research and Development, Sales and Marketing Alzheimer's, pharma, tencent

Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …

News
alzheimers_pharmafocus_accompanying_image

A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated

September 20, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …

Feature
pharmafocus_oct_2018

The September 2018 issue of Pharmafocus is available to read online now!

September 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance

The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …

News
800px-bill_og_melinda_gates_2009-06-03_bilde_01

Bill Gates commits $30m towards Alzheimer’s diagnostic test

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis

Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …

News
nerve-cell-2213009_960_720

Another failure in Alzheimer’s creates bleak outlook for treatment

June 12, 2018
Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025